Monogram Technologies Inc Quick Ratio (MGRM) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Monogram technologies inc   (NASDAQ: MGRM)

Monogram Technologies Inc 's Quick Ratio

MGRM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2025, Quick Ratio fell to 2.06 below Monogram Technologies Inc average.

Within Medical Equipment & Supplies industry 64 other companies have achieved higher Quick Ratio than Monogram Technologies Inc in second quarter 2025. While Quick Ratio total ranking in the second quarter 2025 has deteriorated compared to the prior quarter from 397 to 954.

Explain Quick Ratio?
How much Cash & cash equivalents MGRM´s has?
What are MGRM´s Current Liabilities?




MGRM Quick Ratio (Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
Y / Y Current Liabilities Change 151.25 % -0.28 % -45.32 % -57.3 % -69.33 %
Y / Y Cash & cash equivalent Change 75.66 % 31.68 % 15.23 % 11.36 % -57.27 %
Quick Ratio MRQ 2.06 6.71 10.16 6.5 2.95
MGRM's Total Ranking # 954 # 397 # 186 # 438 # 551
Seq. Current Liabilities Change 214.86 % 28.36 % -39.5 % 2.76 % 24.96 %
Seq. Cash & cash equivalent Change -3.29 % -15.25 % -5.48 % 126.73 % -27.5 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 65
Healthcare Sector # 444
Overall Market # 954


Quick Ratio Statistics
High Average Low
10.16 4.37 0.83
(Dec 31 2024)   (Mar 31 2023)




Financial Statements
Monogram Technologies Inc 's Current Liabilities $ 6 Millions Visit MGRM's Balance sheet
Monogram Technologies Inc 's Cash & cash equivalent $ 13 Millions Visit MGRM's Balance sheet
Source of MGRM's Sales Visit MGRM's Sales by Geography


Cumulative Monogram Technologies Inc 's Quick Ratio

MGRM's Quick Ratio for the trailling 12 Months

MGRM Quick Ratio

(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -7.19 % -54.67 % -67.35 % -60.34 % -29.6 %
Y / Y Cash & cash equivalent TTM Growth 27.22 % -5.11 % -6.9 % -5.23 % 29.94 %
Quick Ratio TTM 4.74 6.18 5.8 4.84 3.46
Total Ranking TTM # 2972 # 2693 # 2225 # 3122 # 2405
Seq. Current Liabilities TTM Growth 43.88 % -0.07 % -13 % -25.81 % -29.73 %
Seq. Cash & cash equivalent TTM Growth 10.47 % 6.44 % 4.35 % 3.69 % -17.6 %


On the trailing twelve months basis Due to in Current Liabilities in the Q2 2025 to $6.23 millions, cumulative Quick Ratio decreased to 4.74 above the MGRM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 178 other companies have achieved higher Quick Ratio than Monogram Technologies Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 2693 to 2972.

Explain Quick Ratio?
How much Cash & cash equivalents MGRM´s has?
What are MGRM´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 179
Healthcare Sector # 829
Within the Market # 2972


trailing twelve months Quick Ratio Statistics
High Average Low
6.18 4.29 2.03
(Mar 31 2025)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Medical Equipment & Supplies Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Neuroone Medical Technologies Corp  5.64 $ 8.040  Millions$ 1.426  Millions
Clearpoint Neuro Inc   5.62 $ 41.541  Millions$ 7.398  Millions
Inspire Medical Systems inc   5.60 $ 300.895  Millions$ 53.712  Millions
Outset Medical Inc   4.99 $ 184.090  Millions$ 36.909  Millions
Irhythm Holdings Inc   4.86 $ 545.540  Millions$ 112.352  Millions
Alpha Pro Tech Ltd   4.80 $ 14.464  Millions$ 3.015  Millions
Anika Therapeutics Inc   4.80 $ 77.122  Millions$ 16.081  Millions
Modular Medical Inc  4.66 $ 7.522  Millions$ 1.613  Millions
Tactile Systems Technology Inc   4.57 $ 81.528  Millions$ 17.845  Millions
Nutriband Inc   4.45 $ 6.995  Millions$ 1.572  Millions
Strata Critical Medical Inc   4.41 $ 60.325  Millions$ 13.679  Millions
Autonomix Medical Inc   4.37 $ 8.589  Millions$ 1.965  Millions
Bluejay Diagnostics Inc  4.27 $ 4.443  Millions$ 1.041  Millions
Neuropace Inc   3.62 $ 62.141  Millions$ 17.143  Millions
Co diagnostics Inc   3.60 $ 13.363  Millions$ 3.711  Millions
Carlsmed Inc   3.53 $ 33.472  Millions$ 9.484  Millions
Glaukos Corp  3.47 $ 274.786  Millions$ 79.136  Millions
Sensus Healthcare Inc   3.46 $ 22.162  Millions$ 6.413  Millions
Sharps Technology Inc   3.45 $ 8.322  Millions$ 2.414  Millions
Solana Company  3.37 $ 6.078  Millions$ 1.805  Millions
Pulmonx Corporation  3.36 $ 75.466  Millions$ 22.447  Millions
Staar Surgical Co  3.21 $ 189.883  Millions$ 59.228  Millions
Alphatec Holdings Inc   3.19 $ 157.063  Millions$ 49.169  Millions
Hyperfine Inc   3.18 $ 25.420  Millions$ 7.988  Millions
Intuitive Surgical Inc   3.15 $ 5,326.500  Millions$ 1,692.600  Millions
Glucotrack Inc   3.10 $ 9.555  Millions$ 3.085  Millions
Tenon Medical Inc   3.06 $ 7.846  Millions$ 2.563  Millions
Heartflow Inc   2.92 $ 80.210  Millions$ 27.450  Millions
Edwards Lifesciences Corporation  2.89 $ 4,062.200  Millions$ 1,404.700  Millions
Biolife Solutions Inc   2.89 $ 81.766  Millions$ 28.312  Millions

Date modified: 2026-06-22T16:30:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.